Pfizer: Time for an Anti vaccine CO VID-19 had nothing to do with politics

In an interview for CNN, Bourla has denied that the news of the anti vaccine CO VID-19 had political motivation, as expectations have been earlier for its appearance in the third week of November.

The Trump administration was quick to take credit for Pfizer's promising news.

Vice President Mike Pence wrote on Twitter that Pfizer's development was “off public-private partnership created by President Donald Trump”.

However, Pfizer was not part of the Warp Speed <x0).

The US federal government promised $1.95 billion for Pfizer and its partner BioNTech (BNTX) to help with the distribution of the vaccine once it is ready, but the government is not working directly to help its development, CNN writes.

Trump had called the drug companies, pressuring them for new developments before election day, saying he would like to see a vaccine move faster than some of his health advisers said it was reasonable.

Today, President-elect Joe Biden welcomed the excellent “news” and said it is also important to understand that the end of the battle against COVID-19 will still take time and will be spent many more months before there is a widespread vaccine in the United States.

Although the vaccine is not set to be managed extensively soon, the Pfizer company said it plans to seek authorisation of emergency use by the US Bar and Food Administration immediately after volunteers have been monitored for two months after their second dose of vaccine.

As developments imply that progress is under way, they will do little to soften the winter wave of the Coronavirus in the short term, given that it will reach until 2021 before the dose is available to all Americans.